Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues
- PMID: 19276661
- DOI: 10.4161/cbt.8.10.8132
Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues
Abstract
The Cub and Sushi Multiple Domains-1 (CSMD1) is a tumor suppressor gene on 8p23.2, where allelic loss is both frequent and associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC). To understand the extent of CSMD1 aberrations in vivo, we characterized 184 primary tumors from the head and neck, lung, breast and skin for gene copy number and analyzed expression in our HNSCCs and lung squamous cell carcinomas (SCCs). We detected loss of CSMD1 in a large proportion of HNSCCs (50%), lung (46%) and breast cancers (55%), and to a lesser extent in cutaneous SCCs (29%) and basal cell carcinomas (BCCs, 17%) using array-based comparative genomic hybridization (aCGH). Studying the region more closely with quantitative real-time PCR (qPCR), the loss of CSMD1 increased to 80% in HNSCCs and 93% in lung SCCs. CSMD1 expression was decreased in tumors compared to adjacent benign tissue (65%, 13/20) and was likely due to gene loss in 45% of cases (9/20). We also identified truncated transcripts lacking exons due to DNA copy number loss (30%, 5/17) or aberrant splicing (24%, 4/17). We show loss of CSMD1 in primary HNSCC tissues, and document for the first time that CSMD1 is lost in breast, lung and cutaneous SCCs. We also show that deletions of CSMD1 and aberrant splicing contribute to altered CSMD1 function in vivo.
Similar articles
-
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.Genes Chromosomes Cancer. 2003 Jun;37(2):132-40. doi: 10.1002/gcc.10191. Genes Chromosomes Cancer. 2003. PMID: 12696061
-
Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.Mol Med. 2001 Jul;7(7):442-53. Mol Med. 2001. PMID: 11683369 Free PMC article.
-
Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines.Cancer Cell Int. 2005 Sep 9;5:29. doi: 10.1186/1475-2867-5-29. Cancer Cell Int. 2005. PMID: 16153303 Free PMC article.
-
The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases.Genes (Basel). 2022 Dec 10;13(12):2332. doi: 10.3390/genes13122332. Genes (Basel). 2022. PMID: 36553598 Free PMC article. Review.
-
LRIG and cancer prognosis.Acta Oncol. 2014 Sep;53(9):1135-42. doi: 10.3109/0284186X.2014.953258. Epub 2014 Sep 2. Acta Oncol. 2014. PMID: 25180912 Free PMC article. Review.
Cited by
-
CUB and Sushi Multiple Domains (CSMD1) Gene Polymorphisms and Susceptibilities to Idiopathic Parkinson's Disease in Northern Chinese Han Population: A Case-Control Study.Parkinsons Dis. 2021 Feb 12;2021:6661162. doi: 10.1155/2021/6661162. eCollection 2021. Parkinsons Dis. 2021. PMID: 33628416 Free PMC article.
-
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.Oncotarget. 2016 Nov 22;7(47):76920-76933. doi: 10.18632/oncotarget.12729. Oncotarget. 2016. PMID: 27764775 Free PMC article.
-
Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.Tumour Biol. 2014 May;35(5):4419-23. doi: 10.1007/s13277-013-1581-6. Epub 2014 Jan 10. Tumour Biol. 2014. PMID: 24408017
-
Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas.J Exp Clin Cancer Res. 2024 Apr 1;43(1):98. doi: 10.1186/s13046-024-03019-6. J Exp Clin Cancer Res. 2024. PMID: 38561856 Free PMC article.
-
Genomic insights into head and neck cancer.Cancers Head Neck. 2016;1:1. doi: 10.1186/s41199-016-0003-z. Epub 2016 Jun 3. Cancers Head Neck. 2016. PMID: 29034103 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical